We compare the utility of endophenotypes and phenotypes in the context of CFTR cSNVs in cystic fibrosis, and of LDLR cSNV impact on cardiovascular-related diseases such as familial hypercholesterolemia. This evidence concerns the gene CFTR and cystic fibrosis.